查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1946607

下一代體外診斷（IVD）全球市場報告（2026年）

Next-Generation In Vitro Diagnostics (IVD) Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，下一代體外診斷（IVD）市場發展迅速，預計2025年至2026年將以10.1%的複合年成長率從1179.7億美元成長至1298.9億美元。過去幾年的成長歸因於多種因素，例如感染疾病的日益普及、慢性病負擔的加重、分子診斷技術的日益普及、臨床檢測基礎設施的擴張以及政府對診斷項目的資助。

預計未來幾年，下一代體外診斷（IVD）市場將保持強勁成長，到2030年市場規模將達到1,886.9億美元，複合年成長率（CAGR）為9.8%。預測期內的成長要素包括：精準醫療需求的不斷成長、基因組檢測應用範圍的擴大、照護現場診斷技術的日益普及、醫療保健數位化的不斷提高以及診斷領域研發投入的持續成長。預測期內的關鍵趨勢包括：個人化醫療和伴隨診斷的興起、就地檢驗和分散式檢查的快速普及、多重檢測和高通量檢測技術的融合、對疾病早期檢測和篩檢需求的成長，以及非侵入性檢測和液態生物檢體診斷技術的快速發展。

預計對個人化醫療日益成長的需求將推動下一代體外診斷（IVD）市場的發展。精準醫療是一種基於個人基因譜、環境和生活方式來客製化疾病預防和治療方案的醫療方法。基因組數據的日益普及為個人化醫療的發展提供了支持，使醫療服務提供者能夠根據個體獨特的基因組成開發標靶治療，從而提高治療效果。下一代體外診斷（IVD）透過提供精準的分子和基因資訊來支持個人化醫療，從而為每位患者制定個人化的治療和預防策略。例如，2024年2月，總部位於美國的醫院和醫療機構聯盟－精準醫療聯盟報告稱，美國食品藥物管理局（FDA）在2023年核准了16種針對罕見疾病患者的新型個人化療法，高於2022年的6種。因此，對個人化醫療日益成長的需求正在推動下一代體外診斷（IVD）市場的擴張。

下一代體外診斷 (IVD) 市場的主要企業正透過與技術提供者、研究機構和醫療保健機構建立策略聯盟，加速創新，提高診斷準確性，並擴大個人、企業和政府獲得先進檢測解決方案的管道。策略聯盟是指公司之間相互合作，利用彼此的優勢和資源，實現通用利益和成功。例如，2024 年 10 月，總部位於英國的生物技術公司 Yourgene Health 與總部位於哥倫比亞的人類遺傳診斷公司 Genetix 合作，推出了哥倫比亞首個本地無創產前檢測 (NIPT) 服務。此舉標誌著該地區產前保健領域的重要發展，為孕婦及其家人提供了更快、更可靠、更經濟高效的先進基因篩檢途徑。該服務採用 Yourgene Health 的 IONA Nx NIPT 工作流程，這是一種全面的、獲得 CE 認證的體外診斷 (IVD) 解決方案，具有高度柔軟性、擴充性，並可適應不同的檢體量。這使得Genetix能夠在哥倫比亞各地提供品質有保證的產前篩檢服務。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球新一代體外診斷（IVD）市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 生物技術、基因組學和精準醫學
    • 人工智慧（AI）和自主人工智慧
    • 數位化、雲端運算、巨量資料、網路安全
    • 物聯網、智慧基礎設施和互聯生態系統
    • 工業4.0和智慧製造
  • 主要趨勢
    • 邁向個人化醫療和伴隨診斷
    • 快速推廣就地檢驗和分散式檢查
    • 多重檢測與高通量檢測的整合
    • 對疾病早期檢測和篩檢的需求日益成長
    • 非侵入性和液態生物檢體診斷的發展

第5章 終端用戶產業市場分析

  • 醫院和診所
  • 診斷檢查室
  • 學術研究機構
  • 生物技術和製藥公司
  • CRO（受託研究機構）

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球下一代體外診斷（IVD）市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 全球下一代體外診斷（IVD）市場規模、對比及成長率分析
  • 全球下一代體外診斷（IVD）市場表現：規模與成長，2020-2025年
  • 全球新一代體外診斷（IVD）市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

  • 依產品類型
  • 耗材、設備和軟體
  • 按診斷方式
  • 核心檢查室診斷、就地檢驗、分子診斷
  • 透過使用
  • 腫瘤學或癌症、感染疾病、糖尿病、心臟病學及其他應用領域
  • 最終用戶
  • 醫院/診所、診斷檢查室、學術研究機構和其他最終用戶
  • 按類型細分：消耗品
  • 檢測試劑盒和試劑、檢體袋和試管、密封件和蓋子
  • 按類型細分：設備
  • 自動化樣品製備系統、高通量分子診斷分析儀、次世代定序平台、整合診斷工作站和分析平台、數位PCR系統和先進的即時PCR儀器
  • 按類型細分：軟體
  • 檢查室資訊管理系統、檢體追蹤軟體模組、雲端追蹤軟體

第10章 區域與國家分析

  • 全球新一代體外診斷（IVD）市場：區域表現及預測，2020-2025年、2025-2030年預測、2035年預測
  • 全球新一代體外診斷（IVD）市場：國家、市場表現及預測，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 下一代體外診斷（IVD）市場：競爭格局與市場佔有率，2024年
  • 下一代體外診斷（IVD）市場：公司估值矩陣
  • 下一代體外診斷（IVD）市場：公司概況
    • F Hoffmann La Roche AG
    • Thermo Fisher Scientific Inc
    • Abbott Laboratories
    • Becton Dickinson And Company
    • Agilent Technologies Inc

第37章：其他領先和創新企業

  • Illumina Inc, Sysmex Corporation, Bio Rad Laboratories Inc, Revvity Inc, Exact Sciences Corporation, QIAGEN NV, DiaSorin SpA, Singular Genomics Systems Inc, Guardant Health Inc, Pacific Biosciences Of California Inc, Transasia Bio Medicals Ltd, J Mitra And Co Pvt Ltd, Roche Diagnostics International AG, Hologic Inc, Genetron Health Inc

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年新一代體外診斷（IVD）市場：提供新機會的國家
  • 2030年新一代體外診斷（IVD）市場：提供新機會的細分市場
  • 下一代體外診斷（IVD）市場2030：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME3MNGVD01_G26Q1

Next-generation in vitro diagnostics (IVD) refers to advanced diagnostic tools and technologies that examine biological samples-such as blood, saliva, or tissue-outside the body to identify diseases, conditions, or infections with enhanced accuracy, speed, and personalization. These technologies often incorporate innovations like genomics, artificial intelligence, digital health platforms, and high-throughput sequencing. The main goal of next-generation IVD is to facilitate earlier, more precise, and patient-tailored diagnosis and monitoring of diseases, including cancer, infectious diseases, and genetic disorders.

The primary product categories in next-generation in vitro diagnostics (IVD) include consumables, instruments, software, and others. Core laboratory diagnostics involve centralized testing services that process a wide variety of biological samples using automated, high-throughput instruments and assays. This encompasses types such as core laboratory diagnostics, point-of-care testing, and molecular diagnostics. These tools are applied across various fields, including oncology, infectious diseases, diabetes, cardiology, and other diagnostic areas, serving a diverse range of end users like hospitals and clinics, diagnostic laboratories, academic and research institutions, and other healthcare providers.

Tariffs have moderately impacted the next-generation in vitro diagnostics market by increasing costs associated with imported diagnostic instruments, consumables, and electronic components used in advanced testing platforms. These cost pressures have affected pricing and procurement cycles across molecular diagnostics and point-of-care testing segments, with Asia-Pacific and Europe being the most impacted regions due to their reliance on cross-border manufacturing and sourcing. However, tariffs have also encouraged localization of production, supply chain diversification, and domestic manufacturing investments, supporting long-term resilience and innovation within the market.

The next-generation in vitro diagnostics (ivd) market research report is one of a series of new reports from The Business Research Company that provides next-generation in vitro diagnostics (ivd) market statistics, including next-generation in vitro diagnostics (ivd) industry global market size, regional shares, competitors with a next-generation in vitro diagnostics (ivd) market share, detailed next-generation in vitro diagnostics (ivd) market segments, market trends and opportunities, and any further data you may need to thrive in the next-generation in vitro diagnostics (ivd) industry. This next-generation in vitro diagnostics (ivd) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The next-generation in vitro diagnostics (ivd) market size has grown rapidly in recent years. It will grow from $117.97 billion in 2025 to $129.89 billion in 2026 at a compound annual growth rate (CAGR) of 10.1%. The growth in the historic period can be attributed to rising prevalence of infectious diseases, growing burden of chronic diseases, increased adoption of molecular diagnostics, expansion of clinical laboratory infrastructure, government funding for diagnostic programs.

The next-generation in vitro diagnostics (ivd) market size is expected to see strong growth in the next few years. It will grow to $188.69 billion in 2030 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to increasing demand for precision medicine, expansion of genomic testing applications, growing adoption of point-of-care diagnostics, rising healthcare digitization, increasing investments in diagnostic R&D. Major trends in the forecast period include shift toward personalized and companion diagnostics, rapid adoption of point-of-care and decentralized testing, integration of multiplex and high-throughput assays, rising demand for early disease detection and screening, growth of non-invasive and liquid biopsy diagnostics.

The rising demand for personalized medicine is expected to drive the growth of the next-generation in vitro diagnostics (IVD) market moving forward. Precision medicine is a healthcare approach that tailors disease prevention and treatment based on an individual's genetic profile, environment, and lifestyle. The growth of personalized medicine is fueled by the increasing availability of genomic data, enabling healthcare providers to develop targeted treatments based on a person's unique genetic makeup, resulting in more effective care. Next-generation in vitro diagnostics (IVD) supports personalized medicine by delivering precise molecular and genetic insights that facilitate customized treatment and prevention strategies for individual patients. For example, in February 2024, the Personalized Medicine Coalition, a US-based hospital and healthcare organization, reported that the FDA approved 16 new personalized treatments for rare disease patients in 2023, up from six approvals in 2022. Therefore, the growing demand for personalized medicine is driving the expansion of the next-generation in vitro diagnostics (IVD) market.

Key players in the next-generation in vitro diagnostics (IVD) market are adopting strategic partnerships by collaborating with technology providers, research institutions, and healthcare organizations to accelerate innovation, improve diagnostic accuracy, and broaden access to advanced testing solutions for individuals, businesses, and governments. Strategic partnerships involve companies leveraging each other's strengths and resources to achieve shared benefits and success. For instance, in October 2024, Yourgene Health, a UK-based biotechnology company, partnered with Genetix, a Colombia-based human genetic diagnosis company, to introduce Colombia's first local non-invasive prenatal testing (NIPT) service. This initiative marks a significant advancement in prenatal care within the region, providing expectant parents with faster, more reliable, and cost-effective access to advanced genetic screening. The service employs Yourgene Health's IONA Nx NIPT Workflow, a comprehensive, CE-marked in vitro diagnostic (IVD) solution. This workflow is highly flexible and scalable, accommodating varying sample volumes, and enables Genetix to offer a quality-assured prenatal screening service throughout Colombia.

In February 2023, SD Biosensor Inc., a South Korea-based in-vitro diagnostics company, along with SJL Partners LLC, a South Korea-based investment firm, acquired Meridian Bioscience Inc. for $1.53 billion. Through this acquisition, SD Biosensor aims to leverage Meridian's expertise in diagnostic products and raw materials used in immunological and molecular tests across various applications. Meridian Bioscience Inc. is a US-based diagnostic company specializing in in vitro diagnostic enzymes.

Major companies operating in the next-generation in vitro diagnostics (ivd) market are F Hoffmann La Roche AG, Thermo Fisher Scientific Inc, Abbott Laboratories, Becton Dickinson And Company, Agilent Technologies Inc, Illumina Inc, Sysmex Corporation, Bio Rad Laboratories Inc, Revvity Inc, Exact Sciences Corporation, QIAGEN NV, DiaSorin SpA, Singular Genomics Systems Inc, Guardant Health Inc, Pacific Biosciences Of California Inc, Transasia Bio Medicals Ltd, J Mitra And Co Pvt Ltd, Roche Diagnostics International AG, Hologic Inc, Genetron Health Inc, Seegene Inc, BGI Genomics Co Ltd, Oxford Nanopore Technologies plc

North America was the largest region in the next-generation in vitro diagnostics (IVD) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the next-generation in vitro diagnostics (ivd) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the next-generation in vitro diagnostics (ivd) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The next-generation in vitro diagnostics (IVD) market consists of revenues earned by entities providing services such as genomic testing services, molecular diagnostics services, and companion diagnostics. The market value includes the value of related goods sold by the service provider or included within the service offering. The next-generation in vitro diagnostics (IVD) market also includes sales of molecular diagnostics kits, proteomics-based diagnostic kits, and NGS sample preparation kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Next-Generation In Vitro Diagnostics (IVD) Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses next-generation in vitro diagnostics (ivd) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for next-generation in vitro diagnostics (ivd) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The next-generation in vitro diagnostics (ivd) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product Type: Consumables; Instruments; Software
  • 2) By Diagnostic Modality: Core Laboratory Diagnostics; Point-Of-Care Testing; Molecular Diagnostics
  • 3) By Application: Oncology Or Cancer; Infectious Diseases; Diabetes; Cardiology ; Other Applications
  • 4) By End-User: Hospitals And Clinics; Diagnostic Laboratories; Academic And Research Institutions; Other End Users
  • Subsegments:
  • 1) By Consumables: Assay Kits And Reagents; Specimen Bags and Tubes; Seals and Caps
  • 2) By Instruments: Automated Sample Preparation Systems; High-Throughput Molecular Diagnostic Analyzers; Next-Generation Sequencing Platforms; Integrated Diagnostic Workstations And Analysis Platforms; Digital PCR Systems And Advanced Real-Time PCR Instruments
  • 3) By Software: Laboratory Information Management Systems; Specimen Tracking Software Modules; Cloud-Based Tracking Software
  • Companies Mentioned: F Hoffmann La Roche AG; Thermo Fisher Scientific Inc; Abbott Laboratories; Becton Dickinson And Company; Agilent Technologies Inc; Illumina Inc; Sysmex Corporation; Bio Rad Laboratories Inc; Revvity Inc; Exact Sciences Corporation; QIAGEN NV; DiaSorin SpA; Singular Genomics Systems Inc; Guardant Health Inc; Pacific Biosciences Of California Inc; Transasia Bio Medicals Ltd; J Mitra And Co Pvt Ltd; Roche Diagnostics International AG; Hologic Inc; Genetron Health Inc; Seegene Inc; BGI Genomics Co Ltd; Oxford Nanopore Technologies plc
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Next-Generation In Vitro Diagnostics (IVD) Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Next-Generation In Vitro Diagnostics (IVD) Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Next-Generation In Vitro Diagnostics (IVD) Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Next-Generation In Vitro Diagnostics (IVD) Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Artificial Intelligence & Autonomous Intelligence
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.5 Industry 4.0 & Intelligent Manufacturing
  • 4.2. Major Trends
    • 4.2.1 Shift Toward Personalized And Companion Diagnostics
    • 4.2.2 Rapid Adoption Of Point-Of-Care And Decentralized Testing
    • 4.2.3 Integration Of Multiplex And High-Throughput Assays
    • 4.2.4 Rising Demand For Early Disease Detection And Screening
    • 4.2.5 Growth Of Non-Invasive And Liquid Biopsy Diagnostics

5. Next-Generation In Vitro Diagnostics (IVD) Market Analysis Of End Use Industries

  • 5.1 Hospitals And Clinics
  • 5.2 Diagnostic Laboratories
  • 5.3 Academic And Research Institutions
  • 5.4 Biotechnology And Pharmaceutical Companies
  • 5.5 Contract Research Organizations

6. Next-Generation In Vitro Diagnostics (IVD) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Next-Generation In Vitro Diagnostics (IVD) Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Next-Generation In Vitro Diagnostics (IVD) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Next-Generation In Vitro Diagnostics (IVD) Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Next-Generation In Vitro Diagnostics (IVD) Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Next-Generation In Vitro Diagnostics (IVD) Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Next-Generation In Vitro Diagnostics (IVD) Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Next-Generation In Vitro Diagnostics (IVD) Market Segmentation

  • 9.1. Global Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Consumables, Instruments, Software
  • 9.2. Global Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Diagnostic Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Core Laboratory Diagnostics, Point-Of-Care Testing, Molecular Diagnostics
  • 9.3. Global Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Oncology Or Cancer, Infectious Diseases, Diabetes, Cardiology, Other Applications
  • 9.4. Global Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals And Clinics, Diagnostic Laboratories, Academic And Research Institutions, Other End Users
  • 9.5. Global Next-Generation In Vitro Diagnostics (IVD) Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Assay Kits And Reagents, Specimen Bags and Tubes, Seals and Caps
  • 9.6. Global Next-Generation In Vitro Diagnostics (IVD) Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Automated Sample Preparation Systems, High-Throughput Molecular Diagnostic Analyzers, Next-Generation Sequencing Platforms, Integrated Diagnostic Workstations And Analysis Platforms, Digital PCR Systems And Advanced Real-Time PCR Instruments
  • 9.7. Global Next-Generation In Vitro Diagnostics (IVD) Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Laboratory Information Management Systems, Specimen Tracking Software Modules, Cloud-Based Tracking Software

10. Next-Generation In Vitro Diagnostics (IVD) Market Regional And Country Analysis

  • 10.1. Global Next-Generation In Vitro Diagnostics (IVD) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Next-Generation In Vitro Diagnostics (IVD) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Next-Generation In Vitro Diagnostics (IVD) Market

  • 11.1. Asia-Pacific Next-Generation In Vitro Diagnostics (IVD) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Segmentation By Diagnostic Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Next-Generation In Vitro Diagnostics (IVD) Market

  • 12.1. China Next-Generation In Vitro Diagnostics (IVD) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Segmentation By Diagnostic Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Next-Generation In Vitro Diagnostics (IVD) Market

  • 13.1. India Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Segmentation By Diagnostic Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Next-Generation In Vitro Diagnostics (IVD) Market

  • 14.1. Japan Next-Generation In Vitro Diagnostics (IVD) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Segmentation By Diagnostic Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Next-Generation In Vitro Diagnostics (IVD) Market

  • 15.1. Australia Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Segmentation By Diagnostic Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Next-Generation In Vitro Diagnostics (IVD) Market

  • 16.1. Indonesia Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Segmentation By Diagnostic Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Next-Generation In Vitro Diagnostics (IVD) Market

  • 17.1. South Korea Next-Generation In Vitro Diagnostics (IVD) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Segmentation By Diagnostic Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Next-Generation In Vitro Diagnostics (IVD) Market

  • 18.1. Taiwan Next-Generation In Vitro Diagnostics (IVD) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Segmentation By Diagnostic Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Next-Generation In Vitro Diagnostics (IVD) Market

  • 19.1. South East Asia Next-Generation In Vitro Diagnostics (IVD) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Segmentation By Diagnostic Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Next-Generation In Vitro Diagnostics (IVD) Market

  • 20.1. Western Europe Next-Generation In Vitro Diagnostics (IVD) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Segmentation By Diagnostic Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Next-Generation In Vitro Diagnostics (IVD) Market

  • 21.1. UK Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Segmentation By Diagnostic Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Next-Generation In Vitro Diagnostics (IVD) Market

  • 22.1. Germany Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Segmentation By Diagnostic Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Next-Generation In Vitro Diagnostics (IVD) Market

  • 23.1. France Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Segmentation By Diagnostic Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Next-Generation In Vitro Diagnostics (IVD) Market

  • 24.1. Italy Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Segmentation By Diagnostic Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Next-Generation In Vitro Diagnostics (IVD) Market

  • 25.1. Spain Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Segmentation By Diagnostic Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Next-Generation In Vitro Diagnostics (IVD) Market

  • 26.1. Eastern Europe Next-Generation In Vitro Diagnostics (IVD) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Segmentation By Diagnostic Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Next-Generation In Vitro Diagnostics (IVD) Market

  • 27.1. Russia Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Segmentation By Diagnostic Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Next-Generation In Vitro Diagnostics (IVD) Market

  • 28.1. North America Next-Generation In Vitro Diagnostics (IVD) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Segmentation By Diagnostic Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Next-Generation In Vitro Diagnostics (IVD) Market

  • 29.1. USA Next-Generation In Vitro Diagnostics (IVD) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Segmentation By Diagnostic Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Next-Generation In Vitro Diagnostics (IVD) Market

  • 30.1. Canada Next-Generation In Vitro Diagnostics (IVD) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Segmentation By Diagnostic Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Next-Generation In Vitro Diagnostics (IVD) Market

  • 31.1. South America Next-Generation In Vitro Diagnostics (IVD) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Segmentation By Diagnostic Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Next-Generation In Vitro Diagnostics (IVD) Market

  • 32.1. Brazil Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Segmentation By Diagnostic Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Next-Generation In Vitro Diagnostics (IVD) Market

  • 33.1. Middle East Next-Generation In Vitro Diagnostics (IVD) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Segmentation By Diagnostic Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Next-Generation In Vitro Diagnostics (IVD) Market

  • 34.1. Africa Next-Generation In Vitro Diagnostics (IVD) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Segmentation By Diagnostic Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Next-Generation In Vitro Diagnostics (IVD) Market Regulatory and Investment Landscape

36. Next-Generation In Vitro Diagnostics (IVD) Market Competitive Landscape And Company Profiles

  • 36.1. Next-Generation In Vitro Diagnostics (IVD) Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Next-Generation In Vitro Diagnostics (IVD) Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Next-Generation In Vitro Diagnostics (IVD) Market Company Profiles
    • 36.3.1. F Hoffmann La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Thermo Fisher Scientific Inc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Becton Dickinson And Company Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Agilent Technologies Inc Overview, Products and Services, Strategy and Financial Analysis

37. Next-Generation In Vitro Diagnostics (IVD) Market Other Major And Innovative Companies

  • Illumina Inc, Sysmex Corporation, Bio Rad Laboratories Inc, Revvity Inc, Exact Sciences Corporation, QIAGEN NV, DiaSorin SpA, Singular Genomics Systems Inc, Guardant Health Inc, Pacific Biosciences Of California Inc, Transasia Bio Medicals Ltd, J Mitra And Co Pvt Ltd, Roche Diagnostics International AG, Hologic Inc, Genetron Health Inc

38. Global Next-Generation In Vitro Diagnostics (IVD) Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Next-Generation In Vitro Diagnostics (IVD) Market

40. Next-Generation In Vitro Diagnostics (IVD) Market High Potential Countries, Segments and Strategies

  • 40.1 Next-Generation In Vitro Diagnostics (IVD) Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Next-Generation In Vitro Diagnostics (IVD) Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Next-Generation In Vitro Diagnostics (IVD) Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer